Renato SATHLER-AVELAR

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens, BMC Infectious Diseases

Immunity and immune modulation in Trypanosoma cruzi infection. - Abstract - Europe PMC

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens, BMC Infectious Diseases

Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease

SciELO - Brasil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia

Natural Killer Cells: At the Forefront of Modern Immunology

Flowchart of selection and follow-up of the Study Population from the Primary Target Sample.

Renato SATHLER-AVELAR

Professor » Luci Maria Sant Ana Dusse » Faculdade de Farmácia » Departamento de Análises Clínicas e Toxicológicas » Somos UFMG

PDF) Physiology and Pathology of Infectious Diseases: The Autoimmune Hypothesis of Chagas Disease

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens, BMC Infectious Diseases